Chen Shuang, Yang Shize, Xu Shun, Dong Siyuan
Department of Cardiology, The First Hospital of China Medical University, Shenyang, China.
Department of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China.
PeerJ. 2020 May 21;8:e9228. doi: 10.7717/peerj.9228. eCollection 2020.
Sublobar resection (SLR) and radiofrequency ablation (RFA) are the two minimally invasive procedures performed for treating stage I non-small cell lung cancer (NSCLC). This study aimed to compare SLR and RFA for the treatment of stage I NSCLC using the meta-analytical method.
We searched PubMed and Embase for articles published till December 2019 to evaluate the comparative studies and assess the survival and progression-free survival rates and postoperative complications (PROSPERO registration number: CRD42018087587). A meta-analysis was performed by combining the outcomes of the reported incidences of short-term morbidity and long-term mortality. The fixed or random effects model was utilized to calculate the pooled odds ratios (OR) and the 95% confidence intervals.
Four retrospective studies were considered in the course of this study. The studies included a total of 309 participants; 154 were assigned to the SLR group, and 155 were assigned to the RFA group. Moreover, there were statistically significant differences between the one- and three-year survival rates and one- and three-year progression-free survival rates for the two groups, which were in favor of the SLR group. Among the post-surgical complications, pneumothorax and pleural effusion were more common for the SLR group, while cardiac abnormalities were prevalent in the RFA group. There was no difference in prevalence of hemoptysis between SLR and RFA groups, which might be attributed to the limited study sample size.
Considering the higher survival rates and disease control in the evaluated cases, surgical resection is the preferred treatment method for stage I NSCLC. RFA can be considered a valid alternative in patients not eligible for surgery and in high-risk patients as it is less invasive and requires shorter hospital stay.
肺叶下切除(SLR)和射频消融(RFA)是用于治疗Ⅰ期非小细胞肺癌(NSCLC)的两种微创手术。本研究旨在采用荟萃分析方法比较SLR和RFA治疗Ⅰ期NSCLC的效果。
我们检索了截至2019年12月发表在PubMed和Embase上的文章,以评估比较性研究,并评估生存率、无进展生存率和术后并发症(PROSPERO注册号:CRD42018087587)。通过合并报告的短期发病率和长期死亡率的结果进行荟萃分析。采用固定效应模型或随机效应模型计算合并比值比(OR)和95%置信区间。
本研究过程中纳入了四项回顾性研究。这些研究共纳入309名参与者;154名被分配到SLR组,155名被分配到RFA组。此外,两组的1年和3年生存率以及1年和3年无进展生存率之间存在统计学显著差异,SLR组更具优势。在术后并发症方面,SLR组气胸和胸腔积液更为常见,而RFA组心脏异常更为普遍。SLR组和RFA组咯血的发生率没有差异,这可能归因于研究样本量有限。
考虑到在评估病例中SLR具有更高的生存率和疾病控制率,手术切除是Ⅰ期NSCLC的首选治疗方法。对于不符合手术条件的患者和高危患者,RFA可被视为一种有效的替代方法,因为它侵入性较小且住院时间较短。